drugset / Trial / NCT05134350
Study of the Effect of Food and a Proton Pump Inhibitor (PPI; Omeprazole) on LOXO-305 in Healthy Participants
RandomizedCrossoverOpen-labelBasic science
Summary
The main purpose of this study is to learn about how food and a PPI (omeprazole) affect LOXO-305 in healthy participants. Participation could last about nine weeks.
Timeline
- Start
- 2020-02-06
- Primary completion
- 2020-03-23
- Completion
- 2020-03-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Omeprazole | Other / unclassified | 40 mg | Oral |
| Subject | Pirtobrutinib | Other / unclassified | 200 mg | Oral |
Indications
No indication recorded.